MassachusettsState Snapshot for Cancer

In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.

Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.

Measures Better Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Breast cancer deaths per 100,000 female population per year 2017 18.5 Better than Average 2000 27.1 Average
Colorectal cancer deaths per 100,000 population per year 2017 11.6 Better than Average 2000 22.0 Worse than Average
Lung cancer deaths per 100,000 population per year 2017 35.2 Better than Average 2000 56.2 Average
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 2016 79.5 Better than Average 2004 95.4 Average
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 2016 8.0 Better than Average 2004 9.7 Better than Average
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 2016 48.7 Better than Average 2004 92.9 Worse than Average
Measures That Are Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy to the breast within 1 year of diagnosis 2016 92.5 Average 2005 91.5 Better than Average
Patients with colon cancer who received surgical resection of colon cancer that included at least 12 lymph nodes pathologically examined 2016 94.3 Average 2005 62.8 Better than Average
Measures Worse Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy) 2016 87.9 Worse than Average 2005 82.5 Worse than Average